Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations

NCT01246401 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

151

Enrollment

OTHER

Sponsor class

Conditions

HIV
AIDS
Opioid Dependence
Drug Dependence

Interventions

DRUG: Extended-Release Naltrexone

Sponsor

Yale University

Collaborators

[object Object]
[object Object]